cycloguanil has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colafrancesco, V; Dugas, JC; Fernandez-Diez, B; Frade, JM; Giralt, E; Lariosa-Willingham, KD; Leonoudakis, D; López-Sánchez, N; Masso, M; Messeguer, A; Messeguer, J; Moreno, B; Pertsovskaya, I; Pulido-Valdeolivas, I; Steinman, L; Teixido, M; Vazquez, R; Vendrell-Navarro, G; Vila, G; Villoslada, P; Zubizarreta, I | 1 |
| González-Ruiz, A; Haworth, SJ; O'Neil, AB; Warhurst, DC | 1 |
2 other study(ies) available for cycloguanil and Disease Models, Animal
| Article | Year |
|---|---|
Axonal and Myelin Neuroprotection by the Peptoid BN201 in Brain Inflammation.
Topics: Amides; Animals; Axons; Disease Models, Animal; Encephalitis; Encephalomyelitis, Autoimmune, Experimental; Female; Fluorescent Antibody Technique; Glaucoma; Male; Mice; Mice, Inbred C57BL; Myelin Sheath; Neuroprotective Agents; Optic Nerve; Peptoids; Proguanil; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Triazines | 2019 |
Dapsone in low doses prevents Pneumocystis carinii pneumonia in the rat model.
Topics: Administration, Oral; Animals; Dapsone; Diet; Disease Models, Animal; Immune Tolerance; Male; Pneumonia, Pneumocystis; Proguanil; Random Allocation; Rats; Rats, Inbred Strains; Triazines | 1991 |